This statistic shows the estimated size of the osteoporosis drugs market in South Korea from 2014 to 2020. In 2020, the osteoporosis drugs market in South Korea is estimated to be worth around 144.7 billion South Korean won.
Estimated size of the osteoporosis drugs market in South Korea from 2014 to 2020 (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Osteoporosis drug market size in China 2008-2016
- Premium Statistic Calcitriol market size in China 2007-2016
- Premium Statistic Market share of anti-osteoporosis drugs in public medical institutions China 2016
- Premium Statistic Anti-cancer drugs estimated market size in South Korea 2014-2020
- Premium Statistic Anti-diabetics estimated market size in South Korea 2014-2020
- Premium Statistic Annual average cost of orphan drugs per patient 2014-2018
- Basic Statistic Major concerns among adults regarding personalized medicine in the U.S. in 2018
- Basic Statistic U.S. opinions on insurance coverage of personalized tests and treatments in 2018
- Premium Statistic Medication types received by clinical research participants globally as of 2017
- Premium Statistic Distribution of incrementally modified drugs approved South Korea 2009-2016, by type
About the region
10
- Premium Statistic Cardiovascular disease drugs estimated market size in South Korea 2014-2020
- Premium Statistic Cholesterol drugs estimated market size in South Korea 2014-2020
- Premium Statistic Most common prescription drugs for prostatic hyperplasia South Korea 2016
- Premium Statistic BPH outpatient prescription medicine sales in South Korea 2016, by age group
- Premium Statistic South Korea's diabetes therapy and drug delivery market size 2014-2023
- Premium Statistic Clock & watch market size South Korea 2013-2022
- Basic Statistic Graduated medical sciences & pharmacy students South Korea 2022, by field
- Premium Statistic Fishery product market size in South Korea 2012-2022
- Premium Statistic Farming & forest product market size in South Korea 2012-2021
- Premium Statistic Food market size in South Korea 2012-2022
Selected statistics
6
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
- Premium Statistic Standard Unit medicine use per capita in the U.S. 2007-2011
Other regions
10
- Basic Statistic Rx medicine exclusion from U.S. pharmacy formularies by company 2014-2022
- Premium Statistic Availability of new medicines in Europe in 2023, by country
- Premium Statistic Leading orphan designations in the EU by indication 2015
- Premium Statistic Number of users of SSRIs in Denmark 2012-2017
- Basic Statistic Number of users of hypertension medicine in Sweden 2022, by age and gender
- Basic Statistic Share of Italians receiving antibiotics from a medical practitioner 2022
- Basic Statistic Global manufacture of other synthetic opioids by type 2014-2021
- Premium Statistic Peru's major pharma import partners by value 2022
- Basic Statistic Dispensing fee per prescription in Canada by drug plan 2021/2022
- Premium Statistic Bolivia: antibiotic imports 2017, by country
Related statistics
10
- Premium Statistic Pharmaceuticals market size South Korea 2012-2022
- Basic Statistic Spending on health per capita South Korea 2012-2022
- Basic Statistic Pharmaceutical spending per capita in South Korea 2000-2022
- Basic Statistic Health spending as percent of GDP in South Korea 2000-2022
- Basic Statistic Pharmaceutical spending as share of GDP South Korea 2000-2022
- Premium Statistic Current health spending in South Korea 1970-2022
- Premium Statistic Drugs for Alzheimer's disease sales in South Korea 2011-2016
- Premium Statistic Prostatic hyperplasia patient number in South Korea 2010-2020
- Premium Statistic Ultrasound bone densitometer market size in South Korea 2010-2015
- Premium Statistic Revenue of GC Pharma 2015-2022
Further related statistics
9
- Merck & Co total assets 2009-2023
- Leading European medtech countries based on market capitalization 2014
- Global pharmaceutical pipeline by therapy area 2013-2017
- Leading banks in the Middle East in 2023, by brand value
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
Further Content: You might find this interesting as well
Statistics
- Merck & Co total assets 2009-2023
- Leading European medtech countries based on market capitalization 2014
- Global pharmaceutical pipeline by therapy area 2013-2017
- Leading banks in the Middle East in 2023, by brand value
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
COMPA. (March 31, 2015). Estimated size of the osteoporosis drugs market in South Korea from 2014 to 2020 (in billion South Korean won) [Graph]. In Statista. Retrieved March 29, 2024, from https://www.statista.com/statistics/771408/south-korea-estimated-market-size-of-osteoporosis-drugs/
COMPA. "Estimated size of the osteoporosis drugs market in South Korea from 2014 to 2020 (in billion South Korean won)." Chart. March 31, 2015. Statista. Accessed March 29, 2024. https://www.statista.com/statistics/771408/south-korea-estimated-market-size-of-osteoporosis-drugs/
COMPA. (2015). Estimated size of the osteoporosis drugs market in South Korea from 2014 to 2020 (in billion South Korean won). Statista. Statista Inc.. Accessed: March 29, 2024. https://www.statista.com/statistics/771408/south-korea-estimated-market-size-of-osteoporosis-drugs/
COMPA. "Estimated Size of The Osteoporosis Drugs Market in South Korea from 2014 to 2020 (in Billion South Korean Won)." Statista, Statista Inc., 31 Mar 2015, https://www.statista.com/statistics/771408/south-korea-estimated-market-size-of-osteoporosis-drugs/
COMPA, Estimated size of the osteoporosis drugs market in South Korea from 2014 to 2020 (in billion South Korean won) Statista, https://www.statista.com/statistics/771408/south-korea-estimated-market-size-of-osteoporosis-drugs/ (last visited March 29, 2024)
Estimated size of the osteoporosis drugs market in South Korea from 2014 to 2020 (in billion South Korean won) [Graph], COMPA, March 31, 2015. [Online]. Available: https://www.statista.com/statistics/771408/south-korea-estimated-market-size-of-osteoporosis-drugs/